Cresset Asset Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1761013
Chicago, IL
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$740,740
+$28,511 QoQ
Shares Held
74,074
-1.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#137
of 316 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $20,925,728 across 13 Drug Manufacturers - Specialty & Generic names. BCRX ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
135,900 | $9,765,774 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
284,488 | $2,796,517 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
23,185 | $2,572,143 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,320 | $2,340,705 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
39,791 | $1,440,434 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
74,074 | $740,740 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,930 | $336,428 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
9,137 | $316,779 |
All Filings in BCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $740,740 | 74,074 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $712,229 | 74,814 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||